Without further ado, let’s get started.
Americans are twice as likely to say that alcohol is “very harmful” than say the same about marijuana, according to a recent survey.
In fact, far more respondents described alcohol, tobacco and e-cigarettes—all legal, regulated products—as seriously dangerous. The number of Americans who said that tobacco cigarettes are “very dangerous” is more than three times the share who believe that about cannabis, which the federal government continues to classify as an illegal Schedule I substance.
The Ontario Cannabis Store sells licensed producers data based on customers’ addresses, Global News has learned.
The Ontario Public Service Employees Union (OPSEU) is calling on Doug Ford to allow the LCBO to compete for cannabis store licenses since private storefronts so far are “an utter disaster”. He says it has been over a year now and the system is still inefficient, and that an LCBO cannabis store would operate much more smoothly.
The Ford government implemented a privatized cannabis sector instead of moving forward with the previous government’s plan to sell pot through a public system.
On August 21, the Alcohol and Gaming Commission of Ontario (AGCO) announced the list of 42 applicants selected by lottery to submit a cannabis Retail Operator Licence and Retail Store Authorization.
It is important to remember that an applicant’s selection in the lottery simply gives them an opportunity to apply for a licence. It is only the first step.
Albertans pull out their wallets for legal weed more often than other Canadians, new data shows. Statistics Canada has published new information on the amount sold at cannabis store across the country, from legalization in October 2018 to June 2019.
The sales data shows that Alberta comes out as the top legal cannabis market in Canada, with more than $123.6 million in sales. Alberta narrowly squeaked into the top spot with Ontario close behind at $121.6 million, followed by Quebec at $119.2 million.
Adult-use cannabis sales through regulated channels in Canada reached a new high in June after meandering for much of the first half-year of legalization, according to the latest, seasonally adjusted data from Statistics Canada.
Sales of regulated adult-use cannabis surpassed 85 million Canadian dollars ($63 million) in June, an improvement over May’s CA$79 million and April’s CA$67 million.
The Justice Department said Monday it would move forward to expand the number of marijuana growers for federally authorized cannabis research.
The long-awaited move comes after researchers filed court papers asking a judge to compel the Drug Enforcement Administration to process the applications to grow research pot. The DEA began accepting applications to grow marijuana for federally approved research about three years ago, but the agency hasn’t acted on the applications.
The latest in the seemingly inevitable march toward full cannabis legalization in the U.S. sees two of the U.S.’s top Federal drug officials stating that legal cannabis should be left up to the states, not the feds.
In a discussion with Fox News reporter Kayla Sullivan, President Trump’s appointed Drug Czar, Jim Carroll – whose official title is Director for the Office of National Drug Control Policy (ONDCP) — stated that he believes the decision to legalize should be left to the states.
In case you aren’t aware, the United States Government currently lists cannabis as a schedule 1 drug in accordance with the Controlled Substances Act (CSA). This means the FDA and DEA believe cannabis has no medical value and has a high potential for abuse. Cannabis sits alongside Heroin, Ecstasy (MDMA) and LSD as the most notable schedule 1 drugs.
The FDA’s recent approval of GW Pharma’s (NASDAQ: GWPH) Epidiolex directly contradicts the U.S. Government’s bizarre schedule 1 classification of cannabis. Clearly, the FDA believes GW Pharma’s cannabis-derived CBD based drug which treats seizures associated with the two rare forms of epilepsy has medical value. It’s very obvious this outdated drug schedule needs to be changed ASAP.
President Donald Trump again said that his administration is allowing states to set their own marijuana policies.
At a press briefing on Friday, the president was asked by DC Examiner reporter Steven Nelson whether cannabis would be federally legalized while he was in office.
Move over Canopy. The world’s largest cannabis company is set to IPO in less than 30 days.
Get the full details here so you don’t miss out on the next potential 10 bagger.